Literature DB >> 33451061

pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of Giardia intestinalis.

Isabel González-Alvarez1, Verónica Vivancos1, Carmen Coll2,3,4,5, Bárbara Sánchez-Dengra1, Elena Aznar2,3, Alejandro Ruiz-Picazo1, Marival Bermejo1, Félix Sancenón2,3,4,5, María Auxiliadora Dea-Ayuela6, Marta Gonzalez-Alvarez1, Ramón Martínez-Máñez2,3,4,5.   

Abstract

Giardiasis is a parasitism produced by the protozoa Giardia intestinalis that lives as trophozoite in the small intestine (mainly in the duodenum) attached to the intestinal villus by means of billed discs. The first line treatment is metronidazole, a drug with high bioavailability, which is why to obtain therapeutic concentrations in duodenum, it is necessary to administer high doses of drug to patients with the consequent occurrence of side effects. It is necessary to developed new therapeutical approaches to achieve a local delivery of the drug. In this sense, we have developed gated mesoporous silica microparticles loaded with metronidazole and with a molecular gate pH dependent. In vitro assays demonstrated that the metronidazole release is practically insignificant at acidic pHs, but in duodenum conditions, the metronidazole delivery from the microparticles is effective enough to produce an important parasite destruction. In vivo assays indicate that this microparticulate system allows to increase the concentration of the drug in duodenum and reduce the concentration in plasma avoiding systemic effects. This system could be useful for other intestinal local treatments in order to reduce doses and increase drug availability in target tissues.

Entities:  

Keywords:  G. intestinalis; mesoporous microparticles; molecular gate; oral administration; targeted drug delivery

Year:  2021        PMID: 33451061      PMCID: PMC7828499          DOI: 10.3390/pharmaceutics13010094

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  30 in total

1.  Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.

Authors:  A J Coupe; S S Davis; I R Wilding
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 2.  New directions in the assessment of gastric function: clinical applications of physiologic measurements.

Authors:  Jason Bratten; Michael P Jones
Journal:  Dig Dis       Date:  2006       Impact factor: 2.404

3.  Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release.

Authors:  Brian G Trewyn; Igor I Slowing; Supratim Giri; Hung-Ting Chen; Victor S-Y Lin
Journal:  Acc Chem Res       Date:  2007-07-24       Impact factor: 22.384

4.  An Interactive Model of Communication between Abiotic Nanodevices and Microorganisms.

Authors:  Beatriz de Luis; Antoni Llopis-Lorente; Paola Rincón; José Gadea; Félix Sancenón; Elena Aznar; Reynaldo Villalonga; José Ramón Murguía; Ramón Martínez-Máñez
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-19       Impact factor: 15.336

Review 5.  Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.

Authors:  Alexander Fuchs; Mathew Leigh; Bastian Kloefer; Jennifer B Dressman
Journal:  Eur J Pharm Biopharm       Date:  2015-05-29       Impact factor: 5.571

Review 6.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study.

Authors:  Douglas S Berkman; Andres G Lescano; Robert H Gilman; Sonia L Lopez; Maureen M Black
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

8.  Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease.

Authors:  Adrián H Teruel; Édgar Pérez-Esteve; Isabel González-Álvarez; Marta González-Álvarez; Ana M Costero; Daniel Ferri; Pablo Gaviña; Virginia Merino; Ramón Martínez-Máñez; Félix Sancenón
Journal:  Mol Pharm       Date:  2019-04-29       Impact factor: 4.939

9.  Molecular gates in mesoporous bioactive glasses for the treatment of bone tumors and infection.

Authors:  Lorena Polo; Natividad Gómez-Cerezo; Elena Aznar; José-Luis Vivancos; Félix Sancenón; Daniel Arcos; María Vallet-Regí; Ramón Martínez-Máñez
Journal:  Acta Biomater       Date:  2016-12-09       Impact factor: 8.947

10.  Surfactant-Triggered Molecular Gate Tested on Different Mesoporous Silica Supports for Gastrointestinal Controlled Delivery.

Authors:  Elisa Poyatos-Racionero; Isabel González-Álvarez; Marta González-Álvarez; Ramón Martínez-Máñez; M Dolores Marcos; Andrea Bernardos; Elena Aznar
Journal:  Nanomaterials (Basel)       Date:  2020-06-30       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.